Ruxolitinib Plus Abemaciclib Shows Promising Results in Myelofibrosis Treatment
Myelofibrosis is a rare and serious blood cancer that affects the bone marrow, leading to impaired blood cell production and
May 2, 2026
Cancer Medicine
Cancer Medicine
FDA Fast-Tracks Lirafugratinib for FGFR2+ Cholangiocarcinoma Treatment
Cholangiocarcinoma, also known as bile duct cancer, is a rare but aggressive form of cancer with limited treatment options—especially in
April 7, 2026
Cancer Medicine
Osimertinib (Tagrisso) for Lung Cancer: What You Need to Know
Introduction Lung cancer is one of the most common and deadly cancers globally. The most common type of lung cancer is non-small
January 30, 2025